The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Ascendis Pharma A/S | COM | 04351P101 | 58,060 | 504,210 | SH | SOLE | 504,210 | 0 | 0 | ||
| Axsome Therapeutics Inc | COM | 05464T104 | 22,993 | 892,946 | SH | SOLE | 892,946 | 0 | 0 | ||
| Bellerophon Therapeutics | COM | 078771102 | 2,490 | 4,149,378 | SH | SOLE | 4,149,378 | 0 | 0 | ||
| BioCryst Pharmaceuticals Inc | COM | 09058V103 | 10,895 | 2,874,602 | SH | SOLE | 2,874,602 | 0 | 0 | ||
| Biohaven Pharmaceuticals | COM | G11196105 | 42,166 | 962,903 | SH | SOLE | 962,903 | 0 | 0 | ||
| Constellation Pharmaceuticals | COM | 210373106 | 8,924 | 726,677 | SH | SOLE | 726,677 | 0 | 0 | ||
| Gemphire Therapeutics | COM | 36870A108 | 382 | 471,524 | SH | SOLE | 471,524 | 0 | 0 | ||
| Kadmon Holdings Inc. | COM | 48283N106 | 514 | 249,463 | SH | SOLE | 249,463 | 0 | 0 | ||
| Kalvista Pharmaceuticals | COM | 483497103 | 8,348 | 376,889 | SH | SOLE | 376,889 | 0 | 0 | ||
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | 8,247 | 609,081 | SH | SOLE | 609,081 | 0 | 0 | ||
| La Jolla Pharmaceuticals | COM | 503459604 | 4,792 | 518,102 | SH | SOLE | 518,102 | 0 | 0 | ||
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | 3,087 | 743,876 | SH | SOLE | 743,876 | 0 | 0 | ||
| Milestone Pharmaceuticals Inc | COM | 59935V107 | 4,033 | 148,560 | SH | SOLE | 148,560 | 0 | 0 | ||
| Obseva SA | COM | H5861P103 | 25,475 | 2,252,460 | SH | SOLE | 2,252,460 | 0 | 0 | ||
| Protagonist Therapeutics Inc | COM | 74366E102 | 5,168 | 426,781 | SH | SOLE | 426,781 | 0 | 0 | ||
| Proteostasis Therapeutics Inc | COM | 74373B109 | 128 | 130,733 | SH | SOLE | 130,733 | 0 | 0 | ||
| Ra Pharmaceuticals | COM | 74933V108 | 20,362 | 677,164 | SH | SOLE | 677,164 | 0 | 0 | ||
| Shockwave Medical Inc | COM | 82489T104 | 51,453 | 901,256 | SH | SOLE | 901,256 | 0 | 0 | ||
| Spero Therapeutics Inc | COM | 84833T103 | 5,456 | 474,015 | SH | SOLE | 474,015 | 0 | 0 | ||
| Tricida Inc | COM | 89610F101 | 16,918 | 428,731 | SH | SOLE | 428,731 | 0 | 0 | ||
| Zogenix | COM | 98978L204 | 17,297 | 362,010 | SH | SOLE | 362,010 | 0 | 0 | ||